IMS DC Slides FULL web

10/31/2017

,QWHUQDWLRQDO0\HORPD6RFLHW\

7KH,QWHUQDWLRQDO0\HORPD6RFLHW\ ‡ (VWDEOLVKHGDVQRQSURILWFRUSRUDWLRQLQ ‡ $LPVWRSURPRWHUHVHDUFKHGXFDWLRQFOLQLFDO VWXGLHVDQGZRUNVKRSVWRLPSURYHSUHYHQWLRQ GLDJQRVLVSURJQRVLVDQGWUHDWPHQWRIPXOWLSOH P\HORPDDQGUHODWHGGLVRUGHUVIRUSDWLHQWV ZRUOGZLGH

3/($6(-2,172'$2organs CardiacresponseatCR (8patientsevaluable) Renal response at CR (18evaluable) BMPC(%)(diagnosis)

MRD+(N=9) N(%) median(range) 5(72) 63(55Ͳ68)

MRDͲ (N=12) N(%) median(range) 4(44) 58(54Ͳ76)

0.156 0.269

3(33)/9(100) 0(0)/4(44) 1/2(50)

7(58)/10(83) 1(8)/6(50) 4/6(66)

0.301/0.337 0.543/0.820 0.750

3/9(33)

6/9(66)

0.201

9(4Ͳ30)

7(3Ͳ20)

0.306

P

Results ‡ A further improvement of cardiac function compared to the time of CR attainment ‡ All 5 evaluable patients with MRDͲ; while Zero of 2 MRD + (P=0.047). ‡ Renal response ‡ 7 of 8 (87%) subjects with MRDͲ; while 4 of 8 (50%) with MRD+ (P=0.153). ‡ Overall, further improvement of cardiac or renal function after CR was significantly associated with absence of MRD (P=0.012).



0HWKRGRORJLFDO /LPLWDWLRQV ‡ %0EDVHG 05'HYDOXDWLRQ OLPLWHG WRRQHVLWH ‡ 3ODVPDF\WRPD" 6ROXWLRQV ‡ ,PDJLQJWHFKQLTXHV3(7&7 ‡ FI'1$ VHTXHQFLQJ DQDO\VHV"Æ RQJRLQJ ‡ &LUFXODWLQJ WXPRUFHOO $QDO\VLV

3URJQRVWLF6LJQLILFDQFHRI,PDJLQJ&5 3(7&7

-HQV+LOOHQJDVV8QLYHUVLW\RI+HLGHOEHUJ6'*

05,

=DPDJQL$6++LOOHQJDVV+DHPDWRORJLFD



3URJQRVWLFVLJQLILFDQFHRIUHVLGXDOOHVLRQVLQ 3(7&7

1 3(7&7DIWHUWKHUDS\  &5 &5SWV KDGUHVLGXDOOHVLRQVLQ3(7&7 0HGLDQ3)6 3(7  PRQWKV 3(7  PRQWKV

-HQV+LOOHQJDVV8QLYHUVLW\RI+HLGHOEHUJ6'*

=DPDJQL &OLQ &DQFHU5HV

3URJQRVWLFVLJQLILFDQFHRIUHVLGXDOOHVLRQVLQ 3(7&7 ± ,)0')&,VWXG\

$WGLDJQRVLV 05,SRVLWLYHLQ  3(7&7SRVLWLYHLQ 0F1HPDUWHVW SYDOXH  

0RUHDX-&2



3URJQRVWLF6LJQLILFDQFHRI5HVLGXDO/HVLRQVLQ 05,EHIRUH0DLQWHQDQFH

3 

3 

0RUHDX-&2

-HQV+LOOHQJDVV8QLYHUVLW\RI+HLGHOEHUJ6'*

3URJQRVWLF6LJQLILFDQFHRI5HVLGXDO/HVLRQVLQ 3(7&7EHIRUH0DLQWHQDQFH

3 

-HQV+LOOHQJDVV8QLYHUVLW\RI+HLGHOEHUJ6'*

3 

0RUHDX-&2



:H1HHG7R0RYH2Q« ‡ 'RZHWUHDWSDWLHQWVZLWK05' YV05' VWDWXVGLIIHUHQWO\" ‡ 'HYHORS05'EDVHGVWXGLHVWRGHFLGH ± :KHWKHU05' ‡ QHHGVFRQVROLGDWLRQDQGRUPDLQWHQDQFH ‡ 7\SHDQGOHQJWKRIPDLQWHQDQFH"

± 6KRXOGDOOSDWLHQWDFKLHYH05' VWDWXV ± :KHWKHU05'VKRXOGJHWPRUHWUHDWPHQWGRZH WUHDWWKHPDVUHVLVWDQWSDWLHQWV" ± 'RHVHDUO\GHWHFWLRQRIDSSHDUDQFHRIFORQDO FHOOVLQGLFDWLYHRIFOLQLFDOO\PHDQLQJIXOUHODSVH" ‡ 'RHVLWVXJJHVWQHHGIRULQWHUYHQWLRQ"

05'$VVHVVPHQW,VD7RROWR0HDVXUH 5HVSRQVHLQ3DWLHQWV:LWK00 05'QHJDWLYLW\LVFRUUHODWHGZLWKORQJHU3)6 Establish standard definition for MRD negativity and timing of MRD assessment ‡ ‡

,0:*FULWHULDGHILQLWLRQRI VHQVLWLYLW\ %XWPD\QHHGUHYLVLRQ 2SWLPDOWLPLQJRI05'DVVHVVPHQWDW&59*35" Optimize MRD assessment techniques ‡ 6HQVLWLYLW\

‡ $FFHVVLELOLW\

‡ )HDVLELOLW\

‡ &RVW

‡ 7KHKLJKHVWVHQVLWLYLW\LVWKHPRVWGLVFULPLQDQWÆLVUHTXLUHG ‡ 05'VKRXOGEHWKHREMHFWLYHRIIXWXUHWULDOV ‡ 05'FRXOGLGHQWLI\FXUHGSDWLHQWV



10/31/2017

0DQDJHPHQWRI5HQDO'LVHDVHLQ PRQRFORQDOJDPPRSDWKLHV 1HOVRQ/HXQJ 'LYLVLRQRI1HSKURORJ\DQG+\SHUWHQVLRQ'LYLVLRQRI +HPDWRORJ\ 0D\R&OLQLF5RFKHVWHU

&RQIOLFWRILQWHUHVW *UDQWIURP2PHURV &RUSRUDWLRQ $GYLVRUIRU7KUDVRV 7KHUDSHXWLFVDQG3URWKHQD

1

10/31/2017

5HQDO)XQFWLRQLQ1HZO\'LDJQRVHG003DWLHQWV  H*)5 POPLQP



 

 

 !

      ,

,,

,,,

,9

9

&.'6WDJH 7HUSRV HWDO(XURSHDQ-+DHPDWRO 

&KURQLF.LGQH\'LVHDVHE\,666WDJLQJ  &.' &.'

         ,66,

,66,,

,66,,,

(OHIWKHUDNLV3DSDSLDNRYRX HWDO/HXNHPLD/\PSKRPD

2

10/31/2017

5HQDOLPSDLUPHQW6FU !ȝPRO/ LQFUHDVHV ZLWKPRUHDGYDQFHGGLVHDVH'XULH6DOPRQ  

          

  '6,

'6,,

'6,,, %ODGHHWDO$UFK,QW 0HG

5HQDOLPSDLUPHQWLVDKLJKULVNP\HORPD GHILQLQJHYHQWV 6FU !XPRO/PJGO 6FU !XPRO/PJGO

%ODGHHWDO$UFK,QW 0HG .QXGVHQHWDO(XU -+DHPDWRO 

3

10/31/2017

5HYHUVLQJ5HQDO,PSDLUPHQW,PSURYHV 2YHUDOO6XUYLYDO

%ODGHHWDO$UFK,QW 0HG .QXGVHQHWDO(XU -+DHPDWRO

'LPRSRXORVHWDO$QQ2QFRO

4

10/31/2017

6FKHLG HWDO+DHPDWRORJLFD 

'LDJQRVWLFFULWHULDRISODVPDFHOO G\VFUDVLDV 0*86

600

00

JG/

t JG/

t JG/

%RQH0DUURZ3&



t 

t 

+\SHUFDOFHPLD &

DEVHQW

DEVHQW



5HQDOLPSDLUPHQW5

DEVHQW

DEVHQW



$QHPLD$

DEVHQW

DEVHQW



/\WLFOHVLRQV%

DEVHQW

DEVHQW







!



!

”

!

0VSLNH

)UHHOLJKWFKDLQUDWLR

%RQHPDUURZSODVPDFHOOV  %RQHOHVLRQRQ05,

&DVWQHSKURSDWK\

”

2EVHUYH2EVHUYH&OLQ WULDO 7UHDW 5DMNXPDU HWDO/DQFHW2QFRO 

5

10/31/2017

/LJKW&KDLQ&DVW1HSKURSDWK\

&RXUWHV\RI'U6DPLK1DVU

6

10/31/2017

+LJKOHYHOVRIPRQRFORQDO)/&DUH UHTXLUHGWRIRUPOLJKWFKDLQFDVW QHSKURSDWK\ 7R[LF LQMXU\

*ORPHUXOXV

3&7

'7

&RUWH[ &&7

/LJKWFKDLQV ILOWHUHG 35 &DVW LQMXU\

2XWHU PHGXOOD

7$/ /&7+3 FDVW

,QQHU PHGXOOD &3 :LQHDUOV.LGQH\,QW

5LVNRI&DVW1HSKURORJ\E\V)/& OHYHO   3DWLHQW

        







!

V)/&PJG/

/HXQJHWDO.LGQH\,QW  +XWFKLVRQHWDO&OLQ -$61

7

10/31/2017

'UD\VRQHWDO%ORRG

8ULQDU\$OEXPLQ([FUHWLRQ

/HXQJHWDO&-$61

8

10/31/2017

3UHFLSLWDQWVRIFDVWQHSKURSDWK\

:LQHDUOV.LGQH\,QW

,PSURYHPHQWRIDFXWHUHQDOIXQFWLRQLQSDWLHQWV ZLWK00 p = 0.05 12

> 50% reduction

 &DVWQHSKURSDWK\

11 < 50% reduction

 !UHGXFWLRQLQWKH LQYROYHGV)/&

3DWLHQWV

10

8

8 6

6

4

3

2 0 5HQDO1RQ5HVSRQGHUV

5HQDO5HVSRQGHUV

/HXQJHWDO.LGQH\,QW

9

10/31/2017

3UREDELOLW\RI5HQDO5HVSRQVHE\'HSWKDQG 6SHHGRIV)/&5HGXFWLRQ

+XWFKLVRQHWDO-$P6RF 1HSKURO 

3ODVPDSKHUHVLVDQGFDVWQHSKURSDWK\

)HHVW HWDO%0- &ODUNHWDO$QQ,QW 0HG

10

10/31/2017

+&2GLDO\]HUWULDOV 3RVLWLYH

1HJDWLYH

0DQDJHPHQWRIFDVWQHSKURSDWK\  +\GUDWLRQ D

+DOIQRUPDOVDOLQH

 (OLPLQDWHDQGDYRLGQHSKURWR[LQV D E F G

16$,'V $&(LQKLELWRU$5% DQWLELRWLFVDQWLIXQJDO &RQWUDVWDJHQWV

 &RUUHFWK\SHUFDOFHPLD 

3DPLGURQDWH

 6WDUWFKHPRWKHUDS\  

%RUWH]RPLE +LJKGRVHGH[DPHWKDVRQH

11

10/31/2017

,QWHUQDWLRQDO.LGQH\DQG0RQRFORQDO *DPPRSDWK\5HVHDUFK*URXS

12

10/31/2017

0RQRFORQDO*DPPRSDWK\RI5HQDO 6LJQLILFDQFH0*56 0*86

600

00

JG/

t JG/

t JG/

%RQH0DUURZ3&



t 

t 

+\SHUFDOFHPLD &

DEVHQW

DEVHQW



5HQDOLPSDLUPHQW5

DEVHQW

DEVHQW



$QHPLD$

DEVHQW

DEVHQW



/\WLFOHVLRQV%

DEVHQW

DEVHQW







!



!

”

!

0VSLNH

)UHHOLJKWFKDLQUDWLR

%RQHPDUURZSODVPDFHOOV  %RQHOHVLRQRQ05,

&DVWQHSKURSDWK\

”

2EVHUYH2EVHUYH&OLQ WULDO 7UHDW 5DMNXPDU HWDO/DQFHW2QFRO 

0*56 ‡ $KHPDWRORJLFFRQGLWLRQWKDWSURGXFHV QHSKURWR[LFPRQRFORQDOLPPXQRJOREXOLQRU IUDJPHQWZKLFKGRQRWPHHWFULWHULDIRUPXOWLSOH P\HORPDPDOLJQDQWO\PSKRPDFKURQLF O\PSKRF\WLFOHXNHPLD

13

10/31/2017

/LJKWFKDLQUHVWULFWLRQZLWKRUZLWKRXW KHDY\FKDLQUHVWULFWLRQ ,J$

NDSSD

,J$

,J$

1RGHSRVLWV 70$

%ULGRX[HWDO.LGQH\,QW 

14

10/31/2017

)LEULOV ‡ 6ROLG ‡ 5DQGRPO\DUUDQJHG ‡ ± QP ‡ 'LVHDVHV ‡ $,J DP\ORLGRVLV ‡ $/ ‡ $+/ ‡ $+

‡ )LEULOODU\JORPHUXORQHSKULWLV ZLWKPRQRFORQDOGHSRVLWV

0LFURWXEXOHV ‡ ± QP ‡ +ROORZFHQWHU ‡ 3DUDOOHODUUD\V ‡ 'LVHDVHV ‡ ,PPXQRWDFWRLG JORPHUXORSDWK\ ‡ &U\RJOREXOLQHPLF JORPHUXORQHSKULWLV

15

10/31/2017

&U\VWDOV,QFOXVLRQV ‡ /LJKWFKDLQSUR[LPDO WXEXORSDWK\DFTXLUHG )DQFRQL V\QGURPH ‡ &U\VWDOVWRUDJH KLVWLRF\WRVLV ‡ &U\R FU\VWDOJOREXOLQHPLF JORPHUXORQHSKULWLV

8QRUJDQL]HG'HSRVLWV ‡ 0,'' ‡ /&'' ‡ /+&'' ‡ +&''

‡ 3*10,'03*1

&

‡ &JORPHUXORSDWK\ ZLWKPRQRFORQDO JDPPRSDWK\

/OR\GHWDO&.- =DQG HWDO$-.' 6HWKL HWDO$-.'

16

10/31/2017

&DVH ‡ $\HDUROGIHPDOHSDWLHQWSUHVHQWHGWRWKH('LQ 'HFHPEHUFRPSODLQLQJRIQDXVHDORZHU DEGRPLQDOSDLQDQGORZHUH[WUHPLW\VZHOOLQJWKDW GHYHORSHGJUDGXDOO\GXULQJWKHSUHYLRXVPRQWK ‡ SURWHLQXULDRIJGD\ ‡ DVHUXPFUHDWLQLQHRIPJGOPPRO/ 

,J*Ȝ

&DVHFRQWLQXH ‡ 3UHGQLVRQHPJGSOXVP\FRSKHQRODWH PRIHWLO± QRUHVSRQVH ‡ +LJKGRVHPHWK\OSUHGQLVRORQHDQGULWX[LPDE± UHVSRQVH ‡ 3URWHLQXULDJG

‡ 5HODSVHGPRQWKVODWHUZLWKSURWHLQXULDDQG KHPDWXULD ‡ KLJKGRVHPHWK\OSUHGQLVRORQH

‡ 5HODSVHGPRWKVODWHUDJDLQZLWKSURWHLQXULD ‡ KLJKGRVHPHWK\OSUHGQLVRORQH

17

10/31/2017

&DVH ‡  ‡ \R IHPDOHSUHVHQWVZLWKHGHPDDQGK\SHUWHQVLRQ ‡ 6FU ZDVPJGOȝPRO/ ‡ 3URWHLQXULDJG

‡  ‡ 5HQDOELRSV\ZDVSHUIRUPHG ‡ 3UROLIHUDWLYHJORPHUXORQHSKULWLVZLWKPRQRFORQDO LPPXQRJOREXOLQGHSRVLWV



&7'

&\3 7DFUROLPXV GH[DPHWKDVRQH &\3





5LWX[LPDE 

00)





$FDOFXORXV FKROHF\VWLWLV %0%[ 

3URWHLQXULD« 6FUPJGO

                                      



6RDUHV HWDO$P-.LGQH\'LV

18

10/31/2017

6RDUHVHWDO$-.'

+HUUPDQQHWDO&OLQ 1HSKURO 

19

10/31/2017

Am J Kidney Dis 2004; 

(DUO\UHFXUUHQFHLVDPDMRUREVWDFOHIRUNLGQH\WUDQVSODQWDWLRQ

1DVUHWDO&OLQ -$P6RF 1HSKURO 

20

10/31/2017

2YHUDOO6XUYLYDORI(65'3DWLHQWVYV 0XOWLSOH0\HORPD3DWLHQWV

6FKURLMHQ HWDO%0&1HSKURO 

‡ *RDOVRIWKHUDS\ ‡ 3UHVHUYDWLRQRIOLIH $P\ORLGRVLV ‡ 3UHVHUYDWLRQRINLGQH\ IXQFWLRQ ‡ 5HVWRUHWKHHOLJLELOLW\IRU NLGQH\WUDQVSODQWDWLRQ

21

10/31/2017

1DVUHWDO$-.'

9RV HWDO%U-+DHPDWRO 

22

10/31/2017

6WUDWLHWDO+DHPDWRORJLFD 

7UHDWPHQWRI0*56  0DNHWKHGLDJQRVLVRI0*56UHODWHGGLVHDVH  ,GHQWLI\WKHFORQH

23

10/31/2017

6HQVLWLYLW\RIPRQRFORQDOSURWHLQWHVWVLQ PRQRFORQDOJDPPRSDWKLHV

.DW]PDQ HWDO&OLQ &KHP 

0RQRFORQDOSURWHLQLVGHWHFWHGLQRQO\ RIFDVHVLQYROYLQJ3*10,'

%KXWDQLHWDO0D\R&OLQLF3URF 1DVUHWDO-$61

24

10/31/2017

'HWHFWLRQRIWKHPRQRFORQDOSURWHLQ FRUUHODWHVZLWKFORQDOGHWHFWLRQUDWH

%KXWDQLHWDO0D\R&OLQ 3URF 

&ORQHVLGHQWLILHGLQ3*10,'

%KXWDQLHWDO0D\R&OLQ3URF 

25

10/31/2017

$FKLHYHPHQWRI9*35KHOSVSUHVHUYH UHQDOIXQFWLRQLQ$/DP\ORLGRVLV

3DOODGLQL HWDO%ORRG

6D\HGHWDO%ORRG

26

10/31/2017

.RXUHOLV HWDO$P-+HPDWRO 

7UHDWPHQWDQG2XWFRPHVIRU0,''

9*35RUEHWWHULVUHTXLUHGIRU LPSURYHPHQWLQUHQDORXWFRPHV

27

10/31/2017

+HPDWRORJLFUHVSRQVHEDVHGRQIURQWOLQH WUHDWPHQWLQ0,''

$6&7DQ\WLPH











6D\HGHWDO%ORRG

/&37

6&7&KHPR &KHPR$ORQH 1  1 

1RQH 3 YDOXH 1 

6FU PJGO









3URWHLQXULD



 





+HP5HVSRQVH



&5









9*35









35









6'









5HQDO5HVSRQVH



,PSURYHG







6WDEOH







3URJUHVVLRQ







(65'













'HDWK



6WRNHVHWDO-$61

28

10/31/2017

5HQDOUHVSRQVHE\+HPDWRORJLFUHVSRQVH

9LJQRQ HWDO/HXNHPLD

&KDXYHW HWDO%ORRG

29

10/31/2017

7UHDWPHQWPRGDOLW\RIRXWFRPHV

&KDXYHW HWDO%ORRG

&DVWURHWDO/HXNHPLD /\PSKRPD

30

10/31/2017

7KDQN\RXIRU\RXUDWWHQWLRQ 4XHVWLRQV

31

7RZDUGV5LVN$GDSWHG,QGXFWLRQ 7KHUDS\IRU7UDQVSODQWHOLJLEOH 0\HORPD3DWLHQWV 5REHUW=2UORZVNL3K'0' )ORUHQFH0DXGH7KRPDV&DQFHU5HVHDUFK3URIHVVRU &KDLUad interim'HSDUWPHQWRI/\PSKRPD0\HORPD 3ULQFLSDO,QYHVWLJDWRU0'$QGHUVRQ6325(LQ0XOWLSOH0\HORPDDQG6&25 LQ+LJKULVN3ODVPD&HOO'\DFUDVLDV &KDLU6:2*0\HORPD&RPPLWWHH

1&&1*XLGHOLQHV

KWWSVZZZQFFQRUJ9HUVLRQ



,)09$'YV9' ‡ %RUWH]RPLE'H[9'  VXSHULRUWR9$'LQ UHVSRQVHUDWH ± •9*35YV

‡ 7UHQGWRZDUGVEHWWHU ()6 26ZLWKOHVVHU GXUDWLRQRIWKHUDS\ IHZHUQG WUDQVSODQWV +DURXVVHDX-/HWDO-&OLQ2QFRO 

*,0(0$6WXG\97'YV7' ‡ ,QGXFWLRQZLWK ERUWH]RPLEWKDOLGRPLGHGH [97' JDYHVXSHULRU UHVSRQVHUDWHDQTXDOLW\ &5Q&5YV ‡ 6XSHULRU()6DQG3)6 PDLQWDLQHGDIWHUWUDQVSODQW &DYR0HWDO/DQFHW



9DOXHRI%RUWH]RPLELQ,QGXFWLRQ ‡ 0HWDDQDO\VLVRI,)09GYV9$'  +2921*00*+'3$'YV9$'  3(7+(0$*(00(12697GYV7'

6RQQHYHOG3HWDO-&OLQ2QFRO

6XVWDLQHG3RVW$6&7

6RQQHYHOG3HWDO-&OLQ2QFRO



/HQDOLGRPLGH%RUWH]RPLE'H[ ‡ ([FHOOHQW RYHUDOO UHVSRQVHUDWH DQGTXDOLW\ ‡ 'RHVQRW FRPSURPLVH VWHPFHOO FROOHFWLRQ 5LFKDUGVRQ3*HWDO%ORRG

,0)59'6WXG\ ‡ 59'LQGXFWLRQ$6&759'FRQVROLGDWLRQDQG WKHQ5PDLQWHQDQFH

5RXVVHO0HWDO-&OLQ2QFRO



3)6'DWD

5RXVVHO0HWDO-&OLQ2QFRO

59')URP6:2*6

'XULH%*0HWDO/DQFHW



5HVSRQVH'DWD

'XULH%*0HWDO/DQFHW

63)6

'XULH%*0HWDO/DQFHW



626

'XULH%*0HWDO/DQFHW

3$'YV9&G

0DL(.HWDO/HXNHPLD



97'YV9&'

0RUHDX3HWDO%ORRG

2YHUYLHZ ‡ 7ZRRUWKUHHGUXJVZLWKRQHEHLQJDQRYHO DJHQW DUHEHWWHUWKDQWKUHHFRQYHQWLRQDOGUXJV ‡ 9GDQG3$'DUHEHWWHUWKDQ9$' ‡ 9&GLVEHWWHUWKDQ3$' ‡ 97GLVEHWWHUWKDQ9&G ‡ 59GLVEHWWHUWKDQ5G ‡ 59GLVEHWWHUWKDQ97G



,)0')&,6WXG\

$WWDO0HWDO1(QJO-0HG

.5GDVDQ$OWHUQDWLYH

-DNXERZLDN$-HWDO%ORRG



+LJK05' 1HJDWLYH5DWHV ‡ 3RVVLEO\ KLJKHUWKDQ ZLWK59'

.RUGH1HWDO-$0$2QFRO

(&2*$&5,1(1'85$1&(6WXG\



&5LV,PSRUWDQWLQ+LJK5LVN

+DHVVOHU-HWDO&OLQ&DQFHU5HV

,V05'D%HWWHU(QGSRLQW"

/DKXHUWD--HWDO-&OLQ2QFRO



2YHUDOO6XUYLYDO 05'

/DKXHUWD--HWDO-&OLQ2QFRO

'UXJVIRU+LJK5LVN3RP"

/HOHX;HWDO%ORRG



$63,5(6WXG\5HVSRQVH5DWHV

6WHZDUW$.HWDO1(QJO-0HG

3)6'DWD

6WHZDUW$.HWDO1(QJO-0HG



26'DWD

6WHZDUW$.HWDO1(QJO-0HG

+LJK5LVN&DUILO]RPLE"

6WHZDUW$.HWDO1(QJO-0HG



$QWLERGLHV0HFKDQLVPVRI$FWLRQ

9DQGH'RQN1:&-HWDO%ORRG

(/248(177UHDWPHQW5HVSRQVH

/RQLDO6HWDO1(QJO-0HG



3)6&XUYHV

/RQLDO6HWDO1(QJO-0HG

+LJK5LVN(ORWX]XPDE

/RQLDO6HWDO1(QJO-0HG



+LJK5LVN'DUDWXPXPDE

'LPRSRXORV0$HWDO1(QJO-0HG

&RQFOXVLRQV ‡ 7KHFXUUHQWVWDQGDUGRIFDUHIRULQGXFWLRQ WKHUDS\SUHWUDQVSODQWLV59' ‡ .5'LVDUHDVRQDEOHDOWHUQDWLYHJLYHQWKH SRVVLEO\KLJKHU&5UDWHDQGRYHUDOOEHWWHU WROHUDELOLW\ ‡ +LJKULVNSDWLHQWVVKRXOGSUREDEO\EHWUHDWHG PRUHDJJUHVVLYHO\WRDFKLHYHQRWMXVW&5EXW 05'QHJDWLYLW\



0D\R6XJJHVWLRQV

KWWSVPVPDUWRUJ

6$+LJK5LVN6WXG\ 3+$6(,

5$1'20,=('3+$6(,,3257,21

,QGXFWLRQ0DLQWHQDQFH RVD + Elotuzumab 8 cycles of Induction Therapy followed by Maintenance until progression or relapse n=6

RVD x 8 Cycles1,2 Q 

RVD 'RVH UHGXFHG

RVD-Elo x 8 Cycles1,2 Q 

RVD-Elo 'RVH UHGXFHG

Off-Protocol at Progression/ Relapse

 21(&